Management
John W. Huemoeller II
Chief Executive Officer, President
Complete understanding of financial markets, investment banking, capital raising, management, legal, accounting, SEC rules and filings and board management. Analytical, with [20+] years of experience providing leadership and direction to employees. Highly effective sales executive with [20+] years of experience selling a broad array of products to a wide variety of customers.
CEO – Axim Biotechnologies – San Diego, CA August 2019 to Present.
Responsible for all aspects of strategies for acquisitions and divestitures of an SEC fully reporting Company. Oversaw R & D of Covid-19 neutralizing antibody test. Responsible for acquisition of 2 FDA cleared medical devices. Raised over $10MM through various offerings and handled public relations and legal.
CEO – Propell Technologies – Houston, TX February 2015 to August 2019.
Fully reporting public company which acquired Plasma Pulse oil and gas technology from Russia and brought to market in US raising over $5MM. Brought in customers (Chevron, Occidental Petroleum and over 60 independent O&G companies. Redeveloped technology to US standards.
Investment Banker – Aspenwood Capital & Buckmann Buckmann & Reed – Denver, CO January 2013 to February 2016.
Vetted deal flow, brought in deals. Dealt with company management and investors. Completed numerous financings and took companies public. Raised tens of millions of dollars. John has held Series 3, 7, 24, 63 and 79 Securities Licenses, was registered with various state insurance boards, the Chicago Board of Trade as a commodities broker, and worked for various broker-dealers throughout his career including Smith Barney, Drexel Burnham, Prudential Securities, and Paine Webber. Mr. Huemoeller is co-author of several issued U.S. Patents.
Steven T. Wolf
Director
Michael O’Brien
Operations Executive VP
Send A Message
For More Information